Sodium channel Nav1.6 in sensory neurons contributes to vincristine-induced allodynia.

Vincristine, a widely used chemotherapeutic agent, produces painful peripheral neuropathy. The underlying mechanisms are not well understood. In this study, we investigated whether voltage-gated sodium channels are involved in the development of vincristine-induced neuropathy. We established a mouse model in which repeated systemic vincristine treatment results in the development of significant mechanical allodynia. Histological examinations did not reveal major structural changes at proximal sciatic nerve branches or distal toe nerve fascicles at the vincristine dose used in this study. Immunohistochemical studies and in vivo two-photon imaging confirmed that there is no significant change in density or morphology of intra-epidermal nerve terminals throughout the course of vincristine treatment. These observations suggest that nerve degeneration is not a prerequisite of vincristine-induced mechanical allodynia in this model. We also provided the first detailed characterization of tetrodotoxin-sensitive (TTX-S) and resistant (TTX-R) sodium currents in dorsal root ganglion neurons following vincristine treatment. Accompanying the behavioural hyperalgesia phenotype, voltage-clamp recordings of small and medium dorsal root ganglion neurons from vincristine-treated animals revealed a significant upregulation of TTX-S Na+ current in medium but not small neurons. The increase in TTX-S Na+ current density is likely mediated by Nav1.6, because in the absence of Nav1.6 channels, vincristine failed to alter TTX-S Na+ current density in medium dorsal root ganglion neurons and, importantly, mechanical allodynia was significantly attenuated in conditional Nav1.6 knockout mice. Our data show that TTX-S sodium channel Nav1.6 is involved in the functional changes of dorsal root ganglion neurons following vincristine treatment and it contributes to the maintenance of vincristine-induced mechanical allodynia.

[1]  C. Kushida,et al.  Peripheral neuropathy , 2005, Journal of Neurology.

[2]  M. Sweet,et al.  Minocycline Prevents the Development of Mechanical Allodynia in Mouse Models of Vincristine-Induced Peripheral Neuropathy , 2019, Front. Neurosci..

[3]  D. Stainier,et al.  Genetic compensation triggered by mutant mRNA degradation , 2019, Nature.

[4]  Jun-Ming Zhang,et al.  Neonatal vincristine administration modulates intrinsic neuronal excitability in the rat dorsal root ganglion and spinal dorsal horn during adolescence , 2018, Pain.

[5]  Federico Iseppon,et al.  Sodium channels , 2018, Brain and neuroscience advances.

[6]  S. Collina,et al.  Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead. , 2018, Bioorganic & medicinal chemistry letters.

[7]  S. Dib-Hajj,et al.  Conditional knockout of NaV1.6 in adult mice ameliorates neuropathic pain , 2018, Scientific Reports.

[8]  Ryan M. Cassidy,et al.  DRG Voltage-Gated Sodium Channel 1.7 Is Upregulated in Paclitaxel-Induced Neuropathy in Rats and in Humans with Neuropathic Pain , 2017, The Journal of Neuroscience.

[9]  Jeffrey J. Nirschl,et al.  The impact of cytoskeletal organization on the local regulation of neuronal transport , 2017, Nature Reviews Neuroscience.

[10]  M. H. van den Berg,et al.  Vincristine-induced peripheral neuropathy in children with cancer: A systematic review. , 2017, Critical reviews in oncology/hematology.

[11]  K. Aromolaran,et al.  Ion channels and neuronal hyperexcitability in chemotherapy-induced peripheral neuropathy , 2017, Molecular pain.

[12]  I. Vetter,et al.  Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy , 2017, Front. Mol. Neurosci..

[13]  Wonseok Chang,et al.  Expression and Role of Voltage-Gated Sodium Channels in Human Dorsal Root Ganglion Neurons with Special Focus on Nav1.7, Species Differences, and Regulation by Paclitaxel , 2017, Neuroscience Bulletin.

[14]  J. Milbrandt,et al.  Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice. , 2016, Brain : a journal of neurology.

[15]  Shery Jacob,et al.  A simple practice guide for dose conversion between animals and human , 2016, Journal of basic and clinical pharmacy.

[16]  G. Cavaletti,et al.  Chemotherapy-induced peripheral neurotoxicity. , 2015, Current opinion in neurology.

[17]  E. Walters,et al.  Mechanisms involved in the development of chemotherapy-induced neuropathy. , 2015, Pain management.

[18]  W. Xie,et al.  Local knockdown of the NaV1.6 sodium channel reduces pain behaviors, sensory neuron excitability, and sympathetic sprouting in rat models of neuropathic pain , 2015, Neuroscience.

[19]  Elizabeth M. Wells,et al.  Patterns and severity of vincristine‐induced peripheral neuropathy in children with acute lymphoblastic leukemia , 2015, Journal of the peripheral nervous system : JPNS.

[20]  R. Baron,et al.  Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain , 2014, Nature Reviews Neurology.

[21]  S. Bevan,et al.  Monocytes expressing CX3CR1 orchestrate the development of vincristine-induced pain. , 2014, The Journal of clinical investigation.

[22]  S. Dib-Hajj,et al.  Dynamic-clamp analysis of wild-type human Nav1.7 and erythromelalgia mutant channel L858H. , 2014, Journal of neurophysiology.

[23]  S. Waxman,et al.  Sodium Channels Contribute to Degeneration of Dorsal Root Ganglion Neurites Induced by Mitochondrial Dysfunction in an In Vitro Model of Axonal Injury , 2013, The Journal of Neuroscience.

[24]  M. Koltzenburg,et al.  Chemotherapy‐induced peripheral neurotoxicity: A critical analysis , 2013, CA: a cancer journal for clinicians.

[25]  A. A. Romanovsky,et al.  An animal model of oxaliplatin-induced cold allodynia reveals a crucial role for Nav1.6 in peripheral pain pathways , 2013, PAIN®.

[26]  S. Pezet,et al.  Structural and Molecular Alterations of Primary Afferent Fibres in the Spinal Dorsal Horn in Vincristine-Induced Neuropathy in Rat , 2013, Journal of Molecular Neuroscience.

[27]  Ling Ye,et al.  Knockdown of sodium channel NaV1.6 blocks mechanical pain and abnormal bursting activity of afferent neurons in inflamed sensory ganglia , 2013, PAIN®.

[28]  Z. Fei,et al.  Spinal Astrocytic Activation Contributes to Mechanical Allodynia in a Rat Chemotherapy-Induced Neuropathic Pain Model , 2013, PloS one.

[29]  S. Dib-Hajj,et al.  Nav1.8 expression is not restricted to nociceptors in mouse peripheral nervous system , 2012, PAIN®.

[30]  P. Grafe,et al.  Anticancer drug oxaliplatin induces acute cooling-aggravated neuropathy via sodium channel subtype NaV1.6-resurgent and persistent current , 2012, Proceedings of the National Academy of Sciences.

[31]  Nirmal Singh,et al.  Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy. , 2012, Toxicology.

[32]  H. Haapasalo,et al.  Intraepidermal nerve fibre density in cancer patients receiving adjuvant chemotherapy. , 2011, Anticancer research.

[33]  S. Dib-Hajj,et al.  Sodium channels in normal and pathological pain. , 2010, Annual review of neuroscience.

[34]  N. Kiguchi,et al.  Up-regulation of tumor necrosis factor-alpha in spinal cord contributes to vincristine-induced mechanical allodynia in mice , 2008, Neuroscience Letters.

[35]  T. Kondo,et al.  The critical role of invading peripheral macrophage-derived interleukin-6 in vincristine-induced mechanical allodynia in mice. , 2008, European journal of pharmacology.

[36]  C. Loprinzi,et al.  Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. , 2008, European journal of cancer.

[37]  G. Bennett,et al.  Chemotherapy-evoked neuropathic pain: Abnormal spontaneous discharge in A-fiber and C-fiber primary afferent neurons and its suppression by acetyl-l-carnitine , 2008, PAIN.

[38]  Wolfgang Grisold,et al.  Chemotherapy‐induced neuropathy , 2008, Journal of the peripheral nervous system : JPNS.

[39]  Matthew S. Johnson,et al.  A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat , 2007, Proceedings of the National Academy of Sciences.

[40]  P. Dougherty,et al.  Dysfunction in multiple primary afferent fiber subtypes revealed by quantitative sensory testing in patients with chronic vincristine-induced pain. , 2007, Journal of pain and symptom management.

[41]  G. Bennett,et al.  Chemotherapy-evoked painful peripheral neuropathy: Analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit , 2007, Neuroscience.

[42]  G. Bennett,et al.  Paclitaxel- and vincristine-evoked painful peripheral neuropathies: Loss of epidermal innervation and activation of Langerhans cells , 2006, Experimental Neurology.

[43]  J. Sullivan,et al.  Involvement of the TTX-resistant sodium channel Nav 1.8 in inflammatory and neuropathic, but not post-operative, pain states , 2006, Pain.

[44]  C. Sommer,et al.  Heterozygous P0 deficiency protects mice from vincristine‐induced polyneuropathy , 2006, Journal of neuroscience research.

[45]  J. Deleo,et al.  Propentofylline attenuates vincristine-induced peripheral neuropathy in the rat , 2006, Neuroscience Letters.

[46]  J. Kamei,et al.  Effect of mexiletine on vincristine-induced painful neuropathy in mice. , 2006, European journal of pharmacology.

[47]  M. Tallman,et al.  Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. , 2005, Blood.

[48]  J. Kamei,et al.  Possible involvement of the spinal nitric oxide/cGMP pathway in vincristine-induced painful neuropathy in mice , 2005, Pain.

[49]  J. Heimans,et al.  Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening , 2005, Neurology.

[50]  G. Forlani,et al.  Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[51]  S. I. Levin,et al.  Floxed allele for conditional inactivation of the voltage‐gated sodium channel Scn8a (Nav1.6) , 2004, Genesis.

[52]  G. Bennett,et al.  Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy , 2004, Pain.

[53]  S. Paul,et al.  Altered temporal pattern of evoked afferent activity in a rat model of vincristine-induced painful peripheral neuropathy , 2003, Neuroscience.

[54]  P. Dougherty,et al.  Changes in sensory processing in the spinal dorsal horn accompany vincristine-induced hyperalgesia and allodynia , 2003, PAIN®.

[55]  Arnold H. Buss Pathways , 2002, Journal of personality assessment.

[56]  T. Yaksh,et al.  Vincristine-induced allodynia in the rat , 2001, Pain.

[57]  J. Levine,et al.  Damage to the cytoskeleton of large diameter sensory neurons and myelinated axons in vincristine‐induced painful peripheral neuropathy in the rat , 2000, The Journal of comparative neurology.

[58]  A. Eschalier,et al.  Pain related behaviour during vincristine-induced neuropathy in rats. , 1999, Neuroreport.

[59]  J. Levine,et al.  Nociceptor Hyper-Responsiveness during Vincristine-Induced Painful Peripheral Neuropathy in the Rat , 1998, The Journal of Neuroscience.

[60]  J. Levine,et al.  Microtubule disorientation and axonal swelling in unmyelinated sensory axons during vincristine‐induced painful neuropathy in rat , 1998, The Journal of comparative neurology.

[61]  J. Levine,et al.  Vincristine hyperalgesia in the rat: A model of painful vincristine neuropathy in humans , 1996, Neuroscience.

[62]  T. Yaksh,et al.  Quantitative assessment of tactile allodynia in the rat paw , 1994, Journal of Neuroscience Methods.

[63]  D. Yarnitsky,et al.  Full dose vincristine (without 2‐mg dose limit) in the treatment of lymphomas , 1994, Cancer.

[64]  M. Jordan,et al.  Mechanism of inhibition of cell proliferation by Vinca alkaloids. , 1991, Cancer research.

[65]  J. Mendell,et al.  Studies on the pathogenesis of vincristine‐induced neuropathy , 1987, Muscle & nerve.

[66]  V. Devita,et al.  Treatment of the lymphomas. , 1972, Seminars in hematology.

[67]  Pieter Lagrou States , 2019, Europe’s Postwar Periods 1989, 1945, 1918.

[68]  N. Kiguchi,et al.  Involvement of inflammatory mediators in neuropathic pain caused by vincristine. , 2009, International review of neurobiology.

[69]  H. Hartung,et al.  Chemotherapy-induced peripheral neuropathy , 2002, Journal of Neurology.